Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antitumor Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03168438
What this trial is testing

Letetresgene Autoleucel Engineered T Cells Alone and in Combination With Pembrolizumab in NY-ESO-1 Positive Multiple Myeloma

Who this might be right for
Neoplasms
GlaxoSmithKline 6
Testing effectiveness (Phase 2)Study completedNCT03432598
What this trial is testing

Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer

Who this might be right for
Locally Advanced Lung Cancer; Metastatic Lung Cancer
BeiGene 54
Early research (Phase 1)UnknownNCT05868083
What this trial is testing

The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma Multiforme
Shanghai Simnova Biotechnology Co.,Ltd. 16
Early research (Phase 1)Study completedNCT02361723
What this trial is testing

Phase 1a/1b BGB-290 for Advanced Solid Tumors.

Who this might be right for
For Participants With Advanced Solid Tumors Failed With Previous Lines of Treatment
BeiGene 101
Early research (Phase 1)Study completedNCT06001580
What this trial is testing

BR101 Injection Alone in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BioRay Pharmaceutical Co., Ltd. 15
Early research (Phase 1)Ended earlyNCT05389462
What this trial is testing

Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors

Who this might be right for
Advanced Solid Tumors
ADC Therapeutics S.A. 128
Testing effectiveness (Phase 2)Active Not RecruitingNCT05661955
What this trial is testing

Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors.

Who this might be right for
Urothelial CarcinomaRenal Cell CarcinomaMelanoma+1 more
BeiGene 113
Testing effectiveness (Phase 2)Study completedNCT04447755
What this trial is testing

Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)

Who this might be right for
Relapsed or Refractory Solid Tumors
Merck Sharp & Dohme LLC 127
Early research (Phase 1)Looking for participantsNCT06609187
What this trial is testing

GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors

Who this might be right for
Breast CancerSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 20
Early research (Phase 1)Looking for participantsNCT06270706
What this trial is testing

PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumor
Pliant Therapeutics, Inc. 124
Early research (Phase 1)Study completedNCT04047862
What this trial is testing

Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

Who this might be right for
Locally Advanced and Metastatic Solid Tumors
BeiGene 446
Testing effectiveness (Phase 2)Looking for participantsNCT06959615
What this trial is testing

A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration

Who this might be right for
Advanced Solid Tumor
Jacobio Pharmaceuticals Co., Ltd. 334
Early research (Phase 1)Not Yet RecruitingNCT07591285
What this trial is testing

SYS6051 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
CSPC Megalith Biopharmaceutical Co.,Ltd. 114
Testing effectiveness (Phase 2)Looking for participantsNCT07335497
What this trial is testing

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced / Metastatic Solid Tumors
Crescent Biopharma, Inc. 290
Early research (Phase 1)Looking for participantsNCT07092748
What this trial is testing

A Phase Ia/ Ib Study of HS387 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Cancers
Zhejiang Hisun Pharmaceutical Co. Ltd. 110
Early research (Phase 1)Ended earlyNCT03685344
What this trial is testing

Safety and Antitumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaMantle Cell LymphomaFollicular Lymphoma
ADC Therapeutics S.A. 13
Testing effectiveness (Phase 2)UnknownNCT05004142
What this trial is testing

Study of Efficacy, Safety, and Pharmacokinetics of FCN-437c in Combination With Fulvestrant or Letrozole+Goserelin

Who this might be right for
Breast Neoplasms
Ahon Pharmaceutical Co., Ltd. 70
Testing effectiveness (Phase 2)WithdrawnNCT03697824
What this trial is testing

Clinical Trial of Safety, Tolerability and Antitumor Activity of Genetically Engineered T Cells in Combination With Anti-Cancer Agents in Relapsed and Refractory Synovial Sarcoma Expressing New York Esophageal Antigen-1 (NY-ESO-1) and/or LAGE-1a

Who this might be right for
Neoplasms
GlaxoSmithKline
Early research (Phase 1)Looking for participantsNCT06630806
What this trial is testing

Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma

Who this might be right for
Plasma Cell Myeloma Refractory
Sanofi 87
Early research (Phase 1)Looking for participantsNCT04412616
What this trial is testing

ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Advanced EGFR Positive Solid Tumor
Changchun Intellicrown Pharmaceutical Co. LTD 60
Next Page